Clinical Trial Update: Morbidity and Mortality After Esophageal and Esophagogastric Junction Cancer Surgery

View source ↗

Summary

A completed clinical trial evaluating morbidity and mortality after surgery for esophageal cancer and esophagogastric junction cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagogastric Junction
• Esophageal Cancer

Snippet

Sponsor: P. Herzen Moscow Oncology Research Institute | Conditions: Esophageal Cancer, Oesophageal Cancer | Status: COMPLETED